These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

874 related items for PubMed ID: 19672999

  • 21. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M, Lu C, Cheng J, Zhang J, Cao C, Xu J, Xu J, Pan H, Zhong B, Tucker S, Wang D.
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [Abstract] [Full Text] [Related]

  • 22. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH.
    Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768
    [Abstract] [Full Text] [Related]

  • 23. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH, Chen LH.
    Ai Zheng; 2004 Jul 10; 23(7):825-8. PubMed ID: 15248921
    [Abstract] [Full Text] [Related]

  • 24. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC).
    Dhanasekaran R, Kooby DA, Staley CA, Kauh JS, Khanna V, Kim HS.
    J Surg Oncol; 2010 May 01; 101(6):476-80. PubMed ID: 20213741
    [Abstract] [Full Text] [Related]

  • 25. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K, Miyazono N, Inoue H, Nishida H, Kanetsuki I, Nakajo M.
    Cancer; 2000 Apr 01; 88(7):1574-81. PubMed ID: 10738215
    [Abstract] [Full Text] [Related]

  • 26. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF, Chan AO, Wong BC, Hui CK, Ooi GC, Tso WK, Yuan HJ, Wong DK, Lai CL.
    Am J Gastroenterol; 2003 May 01; 98(5):1181-5. PubMed ID: 12809846
    [Abstract] [Full Text] [Related]

  • 27. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW.
    Korean J Hepatol; 2009 Dec 01; 15(4):474-85. PubMed ID: 20037266
    [Abstract] [Full Text] [Related]

  • 28. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
    Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, Girardi L, Cillo U, Burra P, Giacomin A, Farinati F.
    Am J Gastroenterol; 2008 Apr 01; 103(4):914-21. PubMed ID: 18177453
    [Abstract] [Full Text] [Related]

  • 29. Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi H, Yamamoto Y, Ichikawa S, Hasebe A, Yano M, Miyamoto Y, Ninomiya T, Ootani H, Takamura K, Kawasaki H, Otomi Y, Kogame M, Sogabe I, Ishimaru Y, Kashihara K, Miyagawa M, Hirooka M, Hiasa Y, Matsuura B, Michitaka K, Onji M.
    Hepatogastroenterology; 2009 Apr 01; 56(89):213-7. PubMed ID: 19453060
    [Abstract] [Full Text] [Related]

  • 30. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM, Qin H, Wang CB, Fang XH, Ma QY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 01; 29(3):232-5. PubMed ID: 17649645
    [Abstract] [Full Text] [Related]

  • 31. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.
    J Gastroenterol Hepatol; 2008 Mar 01; 23(3):482-90. PubMed ID: 18086115
    [Abstract] [Full Text] [Related]

  • 32. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W, Shi J, Xie WF.
    Liver Int; 2010 May 01; 30(5):741-9. PubMed ID: 20331507
    [Abstract] [Full Text] [Related]

  • 33. Predictors of outcome in patients with unresectable hepatocellular carcinoma receiving transcatheter arterial chemoembolization.
    Shen H, Agarwal D, Qi R, Chalasani N, Liangpunsakul S, Lumeng L, Yoo H, Kwo P.
    Aliment Pharmacol Ther; 2007 Aug 01; 26(3):393-400. PubMed ID: 17635374
    [Abstract] [Full Text] [Related]

  • 34. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP, Yu WS, Wei W.
    Ai Zheng; 2008 Feb 01; 27(2):201-5. PubMed ID: 18279622
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma.
    Yamamoto K, Masuzawa M, Kato M, Kurosawa K, Kaneko A, Ishida H, Imamura E, Park NJ, Shirai Y, Fujimoto K, Michida T, Hayashi N, Ikeda M.
    Semin Oncol; 1997 Apr 01; 24(2 Suppl 6):S6-50-S6-55. PubMed ID: 9151917
    [Abstract] [Full Text] [Related]

  • 36. Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?
    Kim JM, Kwon CH, Joh JW, Kim SJ, Shin M, Kim EY, Moon JI, Jung GO, Choi GS, Lee SK.
    Transplant Proc; 2010 Apr 01; 42(3):821-4. PubMed ID: 20430181
    [Abstract] [Full Text] [Related]

  • 37. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
    Sasaki A, Iwashita Y, Shibata K, Ohta M, Kitano S, Mori M.
    Eur J Surg Oncol; 2006 Sep 01; 32(7):773-9. PubMed ID: 16797156
    [Abstract] [Full Text] [Related]

  • 38. A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
    Peng ZW, Chen MS, Liang HH, Gao HJ, Zhang YJ, Li JQ, Zhang YQ, Lau WY.
    Eur J Surg Oncol; 2010 Mar 01; 36(3):257-63. PubMed ID: 19643561
    [Abstract] [Full Text] [Related]

  • 39. A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.
    Mabed M, Esmaeel M, El-Khodary T, Awad M, Amer T.
    Eur J Cancer Care (Engl); 2009 Sep 01; 18(5):492-9. PubMed ID: 19453695
    [Abstract] [Full Text] [Related]

  • 40. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
    Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS.
    Am Surg; 2002 Sep 01; 68(9):827-31. PubMed ID: 12356160
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.